Annual Current Liabilities
$31.27 M
+$7.68 M+32.57%
December 31, 2023
Summary
- As of February 7, 2025, CAPR annual total current liabilities is $31.27 million, with the most recent change of +$7.68 million (+32.57%) on December 31, 2023.
- During the last 3 years, CAPR annual current liabilities has risen by +$28.30 million (+952.39%).
- CAPR annual current liabilities is now at all-time high.
Performance
CAPR Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Liabilities
$20.48 M
-$1.88 M-8.41%
September 30, 2024
Summary
- As of February 7, 2025, CAPR quarterly total current liabilities is $20.48 million, with the most recent change of -$1.88 million (-8.41%) on September 30, 2024.
- Over the past year, CAPR quarterly current liabilities has dropped by -$1.88 million (-8.41%).
- CAPR quarterly current liabilities is now -44.86% below its all-time high of $37.13 million, reached on March 31, 2023.
Performance
CAPR Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
CAPR Current Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +32.6% | -8.4% |
| 3 y3 years | +952.4% | -13.2% |
| 5 y5 years | +2391.2% | -13.2% |
CAPR Current Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +656.5% | -44.9% | +395.4% |
| 5 y | 5-year | at high | +3382.2% | -44.9% | +2180.1% |
| alltime | all time | at high | >+9999.0% | -44.9% | >+9999.0% |
Capricor Therapeutics Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $20.48 M(-8.4%) |
| Jun 2024 | - | $22.35 M(-15.3%) |
| Mar 2024 | - | $26.38 M(-15.6%) |
| Dec 2023 | $31.27 M(+32.6%) | $31.27 M(-5.0%) |
| Sep 2023 | - | $32.93 M(-6.3%) |
| Jun 2023 | - | $35.15 M(-5.3%) |
| Mar 2023 | - | $37.13 M(+57.4%) |
| Dec 2022 | $23.59 M(+470.6%) | $23.59 M(+1.7%) |
| Sep 2022 | - | $23.19 M(+18.7%) |
| Jun 2022 | - | $19.55 M(+36.5%) |
| Mar 2022 | - | $14.32 M(+246.5%) |
| Dec 2021 | $4.13 M(+39.1%) | $4.13 M(+38.3%) |
| Sep 2021 | - | $2.99 M(-5.8%) |
| Jun 2021 | - | $3.17 M(-15.4%) |
| Mar 2021 | - | $3.75 M(+26.3%) |
| Dec 2020 | $2.97 M(+230.9%) | $2.97 M(+30.4%) |
| Sep 2020 | - | $2.28 M(+18.8%) |
| Jun 2020 | - | $1.92 M(+44.7%) |
| Mar 2020 | - | $1.32 M(+47.5%) |
| Dec 2019 | $898.00 K(-28.5%) | $898.00 K(-6.5%) |
| Sep 2019 | - | $960.70 K(-38.7%) |
| Jun 2019 | - | $1.57 M(+4.4%) |
| Mar 2019 | - | $1.50 M(+19.6%) |
| Dec 2018 | $1.26 M(-24.9%) | $1.26 M(-33.1%) |
| Sep 2018 | - | $1.88 M(+42.1%) |
| Jun 2018 | - | $1.32 M(-10.7%) |
| Mar 2018 | - | $1.48 M(-11.5%) |
| Dec 2017 | $1.67 M(-65.9%) | $1.67 M(-90.0%) |
| Sep 2017 | - | $16.69 M(+0.3%) |
| Jun 2017 | - | $16.64 M(+404.5%) |
| Mar 2017 | - | $3.30 M(-32.6%) |
| Dec 2016 | $4.90 M(-25.0%) | $4.90 M(-26.6%) |
| Sep 2016 | - | $6.67 M(+7.5%) |
| Jun 2016 | - | $6.20 M(-15.5%) |
| Mar 2016 | - | $7.34 M(+12.4%) |
| Dec 2015 | $6.53 M(+3.6%) | $6.53 M(-0.1%) |
| Sep 2015 | - | $6.53 M(-4.8%) |
| Jun 2015 | - | $6.86 M(-9.0%) |
| Mar 2015 | - | $7.55 M(+19.8%) |
| Dec 2014 | $6.30 M(+206.9%) | $6.30 M(+1.7%) |
| Sep 2014 | - | $6.19 M(-4.6%) |
| Jun 2014 | - | $6.49 M(+3.1%) |
| Mar 2014 | - | $6.30 M(+206.8%) |
| Dec 2013 | $2.05 M(+287.9%) | $2.05 M(+73.7%) |
| Sep 2013 | - | $1.18 M(+16.4%) |
| Jun 2013 | - | $1.02 M(+56.5%) |
| Mar 2013 | - | $649.10 K(+22.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2012 | $529.20 K(-2.3%) | $529.20 K(+84.3%) |
| Sep 2012 | - | $287.10 K(+7.5%) |
| Jun 2012 | - | $267.10 K(-45.0%) |
| Mar 2012 | - | $485.30 K(-10.4%) |
| Dec 2011 | $541.40 K(-49.4%) | $541.40 K(-24.6%) |
| Sep 2011 | - | $717.80 K(+64.5%) |
| Jun 2011 | - | $436.30 K(-41.3%) |
| Mar 2011 | - | $743.70 K(-30.4%) |
| Dec 2010 | $1.07 M(+67.7%) | $1.07 M(-28.9%) |
| Sep 2010 | - | $1.50 M(+30.9%) |
| Jun 2010 | - | $1.15 M(+29.3%) |
| Mar 2010 | - | $889.20 K(+39.5%) |
| Dec 2009 | $637.60 K(-52.1%) | $637.60 K(-24.5%) |
| Sep 2009 | - | $844.90 K(+91.8%) |
| Jun 2009 | - | $440.40 K(-43.4%) |
| Mar 2009 | - | $778.40 K(-41.6%) |
| Dec 2008 | $1.33 M(-29.5%) | $1.33 M(+45.1%) |
| Sep 2008 | - | $918.10 K(-8.1%) |
| Jun 2008 | - | $999.50 K(-23.8%) |
| Mar 2008 | - | $1.31 M(-30.6%) |
| Dec 2007 | $1.89 M(+1301.6%) | $1.89 M(+39.2%) |
| Sep 2007 | - | $1.36 M(+707.2%) |
| Jun 2007 | - | $168.10 K(+15.9%) |
| Mar 2007 | - | $145.10 K(+7.6%) |
| Dec 2006 | $134.80 K(+73.0%) | $134.80 K(+7.8%) |
| Sep 2006 | - | $125.00 K(+38.6%) |
| Jun 2006 | - | $90.20 K(+8.4%) |
| Mar 2006 | - | $83.20 K(+6.8%) |
| Dec 2005 | $77.90 K(+31.1%) | $77.90 K(+5.7%) |
| Sep 2005 | - | $73.70 K(+9.7%) |
| Jun 2005 | - | $67.20 K(+0.3%) |
| Mar 2005 | - | $67.00 K(+12.8%) |
| Dec 2004 | $59.40 K(+42.1%) | $59.40 K(+17.9%) |
| Sep 2004 | - | $50.40 K(+1.6%) |
| Jun 2004 | - | $49.60 K(-4.2%) |
| Mar 2004 | - | $51.80 K(+23.9%) |
| Dec 2003 | $41.80 K(+69.9%) | $41.80 K(+18.4%) |
| Sep 2003 | - | $35.30 K(+0.3%) |
| Jun 2003 | - | $35.20 K(+24.4%) |
| Mar 2003 | - | $28.30 K(+15.0%) |
| Dec 2002 | $24.60 K(+167.4%) | $24.60 K(+17.7%) |
| Sep 2002 | - | $20.90 K(+68.5%) |
| Jun 2002 | - | $12.40 K(+39.3%) |
| Mar 2002 | - | $8900.00(-3.3%) |
| Dec 2001 | $9200.00(+922.2%) | $9200.00 |
| Dec 2000 | $900.00(0.0%) | - |
| Dec 1999 | $900.00 | - |
FAQ
- What is Capricor Therapeutics annual total current liabilities?
- What is the all time high annual current liabilities for Capricor Therapeutics?
- What is Capricor Therapeutics annual current liabilities year-on-year change?
- What is Capricor Therapeutics quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Capricor Therapeutics?
- What is Capricor Therapeutics quarterly current liabilities year-on-year change?
What is Capricor Therapeutics annual total current liabilities?
The current annual current liabilities of CAPR is $31.27 M
What is the all time high annual current liabilities for Capricor Therapeutics?
Capricor Therapeutics all-time high annual total current liabilities is $31.27 M
What is Capricor Therapeutics annual current liabilities year-on-year change?
Over the past year, CAPR annual total current liabilities has changed by +$7.68 M (+32.57%)
What is Capricor Therapeutics quarterly total current liabilities?
The current quarterly current liabilities of CAPR is $20.48 M
What is the all time high quarterly current liabilities for Capricor Therapeutics?
Capricor Therapeutics all-time high quarterly total current liabilities is $37.13 M
What is Capricor Therapeutics quarterly current liabilities year-on-year change?
Over the past year, CAPR quarterly total current liabilities has changed by -$1.88 M (-8.41%)